tofacitinib,adalimumab
pfizer,abbvie
['tofa', 'tofacitinib']
cancer risk with tofacitinib vs tnfi in ra:
we learned at #acr21 that
cv-enriched pts: risk (oral surveillance)
all comers: no risk (star-ra) french national healthcare database #acr22 looks at all comers: nothing to separate tofa and tnfi. risk begets risk abst1984 
Rheumatologist and clinical pharmacologist, world traveller pretences on the upswing, sometimes podcast host for @austprescriber and others. All opinions my own